Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, 14 Kaplan St, 49202, Petach Tikva, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eur J Pediatr. 2024 May;183(5):2173-2182. doi: 10.1007/s00431-024-05477-8. Epub 2024 Feb 20.
Celiac disease (CeD) is likely to be associated with growth impairment and poor weight gain. However, long-term growth patterns following diagnosis are poorly characterized. We evaluated long-term anthropometric changes in a large cohort of pediatric patients with CeD. A retrospective chart review of patients diagnosed with CeD between 1999 and 2018 was conducted. Demographic and clinical data were collected, and anthropometrics were analyzed from diagnosis and throughout follow-up. The study included 500 patients (59.8% females, median (IQR) age at diagnosis 5.7 (3.7-8.9) years), with a mean follow-up of 5.5 (range 1.5-16.2) years. Weight, height, and BMI Z-score-for-age (WAZ, HAZ, and BMIZ) increased significantly from a mean (± SD) of - 0.82 (± 1.21), - 0.73 (± 1.16), and - 0.32 (± 1.11) at diagnosis to - 0.41 (± 1.23), - 0.45(± 1.16), and - 0.17 (± 1.14) at last follow-up, respectively (p < 0.001 for WAZ and HAZ and p = 0.002 for BMIZ). The largest improvements were observed in patients diagnosed before 3 years of age (p < 0.01). Patients for whom the final adult height was available (n = 86) improved from HAZ mean (± SD) - 0.89 ± 1.37 at diagnosis to - 0.51 ± 1.28 at adulthood measurement, p < 0.05. Wasting was present in 19.7% and stunting in 16.4% of the cohort at diagnosis and normalized in 77.3% and 64.8%, respectively, within a median (IQR) time of 0.79 (0.42-4.24) and 2.3 (0.72-6.02) years, respectively. Gluten-free diet adherence and frequency of visits were not associated with normalization of wasting or stunting in all age groups. Conclusion: Over a long-term follow-up, pediatric patients with CeD demonstrate significant increases in weight, height, and BMI-for-age. Younger age at diagnosis is associated with greater improvement in weight and linear growth, emphasizing the importance of early diagnosis of CeD. What is Known: • Celiac disease (СeD) is likely to be associated with growth impairment and poor weight gain. • Long-term changes in anthropometric indices after diagnosis of CeD are not well characterized. What is New: • Over a long-term follow-up, pediatric patients with CeD demonstrate significant increases in weight, height, and BMI-for-age. • Young age at diagnosis is associated with larger improvement in weight and linear growth.
乳糜泻(CeD)可能与生长受损和体重增长不良有关。然而,诊断后长期的生长模式特征描述不佳。我们评估了大量儿科 CeD 患者的长期人体测量变化。对 1999 年至 2018 年间诊断为 CeD 的患者进行了回顾性图表审查。收集了人口统计学和临床数据,并从诊断和整个随访过程中分析了人体测量数据。该研究包括 500 名患者(59.8%为女性,诊断时的中位(IQR)年龄为 5.7(3.7-8.9)岁),平均随访时间为 5.5(范围 1.5-16.2)年。体重、身高和体重指数年龄别 Z 评分(WAZ、HAZ 和 BMIZ)从诊断时的平均(±SD)-0.82(±1.21)、-0.73(±1.16)和-0.32(±1.11)显著增加至最后随访时的-0.41(±1.23)、-0.45(±1.16)和-0.17(±1.14)(p<0.001 用于 WAZ 和 HAZ,p=0.002 用于 BMIZ)。在诊断前 3 岁的患者中观察到最大的改善(p<0.01)。对于可获得最终成人身高的患者(n=86),HAZ 平均值(±SD)从诊断时的-0.89±1.37改善至成年测量时的-0.51±1.28(p<0.05)。在诊断时,队列中有 19.7%的患者存在消瘦,16.4%的患者存在发育迟缓,分别在中位数(IQR)时间 0.79(0.42-4.24)和 2.3(0.72-6.02)年内,分别有 77.3%和 64.8%正常化。在所有年龄组中,坚持无麸质饮食和就诊频率与消瘦或发育迟缓的正常化无关。结论:在长期随访中,患有乳糜泻的儿科患者体重、身高和 BMI 年龄别显著增加。诊断时年龄较小与体重和线性生长的改善更大相关,强调早期诊断乳糜泻的重要性。已知内容:•乳糜泻(CeD)可能与生长受损和体重增长不良有关。•诊断后人体测量指标的长期变化特征描述不佳。新内容:•在长期随访中,患有乳糜泻的儿科患者体重、身高和 BMI 年龄别显著增加。•诊断时年龄较小与体重和线性生长的改善更大相关。